Juntao Ran
Overview
Explore the profile of Juntao Ran including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
17
Citations
161
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Wu X, Sun Y, Yang H, Wang J, Lou H, Li D, et al.
Lancet
. 2024 Oct;
404(10463):1668-1676.
PMID: 39426385
Background: Cadonilimab is a bispecific antibody targeting PD-1 and CTLA-4, which has shown substantial clinical benefits in advanced cervical cancer. In the COMPASSION-16 trial, we aimed to evaluate the addition...
2.
Guo Y, Hu J, Li Y, Ran J, Cai H
Sci Rep
. 2023 Mar;
13(1):4051.
PMID: 36899027
In radiotherapy, air-filled ion chamber detectors are ubiquitously used in routine dose measurements for treatment planning. However, its use has been restricted by intrinsic low spatial resolution barriers. We developed...
3.
Ran J, Dai Z, Wang S, Li L, Zheng Y, Qu G, et al.
BMC Med Educ
. 2022 Dec;
22(1):827.
PMID: 36457021
Background: Standardized residency training is an essential aspect of enhancing the ability of cancer prevention and screening of residents. The current study was performed to investigate tumor prevention, screening literacy...
4.
Wang L, Wang X, Zhang G, Ma Y, Zhang Q, Li Z, et al.
Radiat Oncol
. 2021 Sep;
16(1):187.
PMID: 34563216
Pelvic radiotherapy is the key treatment for pelvic malignancies, usually including pelvic primary tumour lesions and lymphatic drainage areas in the pelvic region. Therefore, the intestinal tract in the radiation...
5.
Wang J, Shi W, Miao Y, Gan J, Guan Q, Ran J
Bioengineered
. 2021 Sep;
12(1):6286-6304.
PMID: 34494914
Tumor-infiltrating immune cells (TICs) can serve as an important indicator to evaluate the prognosis and therapeutic response in lung adenocarcinoma (LUAD). The identification of mutated genes that can affect the...
6.
Wang J, Dai Z, Miao Y, Zhao T, Gan J, Zhao C, et al.
Cancer Lett
. 2021 Sep;
521:178-195.
PMID: 34492331
With the identification of "negative immune regulation" defects in the immune system and the continuous improvement of immunotherapy, natural killer cells (NK) have received more attention, especially as tools in...
7.
Fu S, Ma C, Tang X, Ma X, Jing G, Zhao N, et al.
Biosci Rep
. 2021 Sep;
41(9).
PMID: 34486645
Background: The decreased level of miR-192-5p has been reported in several kinds of cancers, including bladder, colon, ovarian, and non-small cell lung cancer. However, the expression and function of miR-192-5p...
8.
Yang Y, Ran J, Wang Y, Zhou Z, Chen D, Feng Q, et al.
Lung Cancer
. 2021 May;
157:116-123.
PMID: 34020823
Purposes: This study aimed to evaluate the role of radiotherapy (RT) and intensity modulated radiation therapy (IMRT) in adjuvant and definitive settings of tracheal-bronchial adenoid cystic carcinoma (TACC) treatment. Materials/methods:...
9.
Ran J, Wang J, Dai Z, Miao Y, Gan J, Zhao C, et al.
Front Public Health
. 2021 May;
9:666282.
PMID: 33968889
Increasing the immunogenicity of tumors is considered to be an effective means to improve the synergistic immune effect of radiotherapy. Carbon ions have become ideal radiation for combined immunotherapy due...
10.
Ran J, Qu G, Chen X, Zhao D
Radiat Oncol
. 2021 Feb;
16(1):38.
PMID: 33608038
Background: Primary tracheal adenoid cystic carcinoma (TACC) is rare and originates from the minor salivary gland. Biologically, TACC results in delayed presentation, and the therapeutic effects of multimodal treatment differ...